Trends in the Epidemiology and Treatment of Pediatric-Onset Multiple Sclerosis in Alberta, Canada.

Published in: Journal of child neurology (2023)

The treatment of children with multiple sclerosis in Alberta has evolved, with a rapid shift in 2019 away from injectables to newer agents, although B-cell therapies-not fingolimod-are now most commonly dispensed.

Keyphrases

multiple sclerosis
young adults
combination therapy
replacement therapy
childhood cancer